5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-10.62%
Negative revenue growth while VALMT.HE stands at 17.99%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.02%
Negative gross profit growth while VALMT.HE is at 15.11%. Joel Greenblatt would examine cost competitiveness or demand decline.
-101.62%
Negative EBIT growth while VALMT.HE is at 36.70%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-104.08%
Negative operating income growth while VALMT.HE is at 37.61%. Joel Greenblatt would press for urgent turnaround measures.
-125.44%
Negative net income growth while VALMT.HE stands at 44.12%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-125.00%
Negative EPS growth while VALMT.HE is at 43.24%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-125.00%
Negative diluted EPS growth while VALMT.HE is at 43.24%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.75%
Share count expansion well above VALMT.HE's 0.61%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.74%
Diluted share count expanding well above VALMT.HE's 0.61%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
980.43%
OCF growth above 1.5x VALMT.HE's 63.30%. David Dodd would confirm a clear edge in underlying cash generation.
99.84%
FCF growth above 1.5x VALMT.HE's 59.14%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-15.18%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 54.90%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-17.25%
Negative 5Y CAGR while VALMT.HE stands at 12.09%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-16.22%
Negative 3Y CAGR while VALMT.HE stands at 2.93%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-36.47%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 366.74%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-50.76%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-59.59%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 48.34%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-213.66%
Negative 10Y net income/share CAGR while VALMT.HE is at 208.36%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-140.00%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-110.32%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
96.74%
10Y equity/share CAGR at 50-75% of VALMT.HE's 155.07%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
15.63%
Below 50% of VALMT.HE's 102.84%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-0.11%
Negative 3Y equity/share growth while VALMT.HE is at 58.93%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.94%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-0.40%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-3.91%
We have a declining book value while VALMT.HE shows 4.85%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
400.22%
We have some new debt while VALMT.HE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.